Skip to main content
Erschienen in: Inflammation 3/2008

01.06.2008

Low Level Laser Therapy (LLLT) Decreases Pulmonary Microvascular Leakage, Neutrophil Influx and IL-1β Levels in Airway and Lung from Rat Subjected to LPS-Induced Inflammation

verfasst von: F. Aimbire, A. P. Ligeiro de Oliveira, R. Albertini, J. C. Corrêa, C. B. Ladeira de Campos, J. P. Lyon, J. A. Silva Jr., M. S. Costa

Erschienen in: Inflammation | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Background and Objective

Low level laser therapy (LLLT) is a known anti-inflammatory therapy. Herein we studied the effect of LLLT on lung permeability and the IL-1β level in LPS-induced pulmonary inflammation.

Study Design/Methodology

Rats were divided into 12 groups (n = 7 for each group). Lung permeability was measured by quantifying extravasated albumin concentration in lung homogenate, inflammatory cells influx was determined by myeloperoxidase activity, IL-1β in BAL was determined by ELISA and IL-1β mRNA expression in trachea was evaluated by RT-PCR. The rats were irradiated on the skin over the upper bronchus at the site of tracheotomy after LPS.

Results

LLLT attenuated lung permeability. In addition, there was reduced neutrophil influx, myeloperoxidase activity and both IL-1β in BAL and IL-1β mRNA expression in trachea obtained from animals subjected to LPS-induced inflammation.

Conclusion

LLLT reduced the lung permeability by a mechanism in which the IL-1β seems to have an important role.
Literatur
1.
Zurück zum Zitat Kips, J. C., J. Tavernier, and R. A. Pauwels. 1992. Tumor necrosis factor causes bronchial hyperresponsiveness in rats. Am. Rev. Respir. Dis. 145:332–336.PubMed Kips, J. C., J. Tavernier, and R. A. Pauwels. 1992. Tumor necrosis factor causes bronchial hyperresponsiveness in rats. Am. Rev. Respir. Dis. 145:332–336.PubMed
2.
Zurück zum Zitat Miller, D. L., K. Welty-Wolf, M. S. Carraway, M. Ezban, A. Ghio, H. Suliman, and C. A. Piantadosi. 2002. Extrinsic coagulation blockade attenuates lung injury and pro-inflammatory cytokine release after intratracheal lipopolysaccharide. Am. J. Respir. Cell Mol. Biol. 26(6):650–658.PubMed Miller, D. L., K. Welty-Wolf, M. S. Carraway, M. Ezban, A. Ghio, H. Suliman, and C. A. Piantadosi. 2002. Extrinsic coagulation blockade attenuates lung injury and pro-inflammatory cytokine release after intratracheal lipopolysaccharide. Am. J. Respir. Cell Mol. Biol. 26(6):650–658.PubMed
3.
Zurück zum Zitat Jansson, A. H., C. Eriksson, and X. Wang. 2004. Lung inflammatory responses and hyperinflation induced by an intratracheal exposure to lipopolysaccharide in rats. Lung 182(3):163–171.PubMedCrossRef Jansson, A. H., C. Eriksson, and X. Wang. 2004. Lung inflammatory responses and hyperinflation induced by an intratracheal exposure to lipopolysaccharide in rats. Lung 182(3):163–171.PubMedCrossRef
4.
Zurück zum Zitat Lappalainen, U., J. A. Whitsett, S. E. Wert, J. W. Tichelaar, and K. Bry. 2005. Interleukin-1b causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am. J. Respir. Cell Mol. Biol. 32:311–318. Lappalainen, U., J. A. Whitsett, S. E. Wert, J. W. Tichelaar, and K. Bry. 2005. Interleukin-1b causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am. J. Respir. Cell Mol. Biol. 32:311–318.
5.
Zurück zum Zitat Johnson, V. J., B. Yucesoy, and M. I. Luster. 2005. Prevention of IL-1 signaling attenuates airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J. Allergy Clin. Immunol. 116(4):851–858.PubMedCrossRef Johnson, V. J., B. Yucesoy, and M. I. Luster. 2005. Prevention of IL-1 signaling attenuates airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J. Allergy Clin. Immunol. 116(4):851–858.PubMedCrossRef
6.
Zurück zum Zitat Wang, C. C., C. L. Fu, Y. H. Yang, Y. C. Lo, L. C. Wang, Y. H. Chuang, and D. M. Chiang. 2006. Adenovirus expressing interleukin-1 receptor antagonist alleviates allergic airway inflammation in a murine model of asthma. Gene Ther. 13(19):1414–1421.PubMedCrossRef Wang, C. C., C. L. Fu, Y. H. Yang, Y. C. Lo, L. C. Wang, Y. H. Chuang, and D. M. Chiang. 2006. Adenovirus expressing interleukin-1 receptor antagonist alleviates allergic airway inflammation in a murine model of asthma. Gene Ther. 13(19):1414–1421.PubMedCrossRef
7.
Zurück zum Zitat Rose, C. E. Jr, C. A. Juliano, D. E. Tracey, T. Yoshimura, and S. M. Fu. 1994. Role of interleukin-1 in endotoxin-induced lung injury in the rat. Am. J. Respir. Cell Mol. Biol. 10(2):214–221.PubMed Rose, C. E. Jr, C. A. Juliano, D. E. Tracey, T. Yoshimura, and S. M. Fu. 1994. Role of interleukin-1 in endotoxin-induced lung injury in the rat. Am. J. Respir. Cell Mol. Biol. 10(2):214–221.PubMed
8.
Zurück zum Zitat Warren, J. S. 1992. Relationship between interleukin-1 beta and platelet-activating factor in the pathogenesis of acute immune complex alveolitis in the rat. Am. J. Pathol. 141(3):551–560.PubMed Warren, J. S. 1992. Relationship between interleukin-1 beta and platelet-activating factor in the pathogenesis of acute immune complex alveolitis in the rat. Am. J. Pathol. 141(3):551–560.PubMed
9.
Zurück zum Zitat Ware, L. B., and M. A. Matthay. 2000. The acute respiratory distress syndrome. N. Engl. J. Med. 342:1334–1349.PubMedCrossRef Ware, L. B., and M. A. Matthay. 2000. The acute respiratory distress syndrome. N. Engl. J. Med. 342:1334–1349.PubMedCrossRef
10.
Zurück zum Zitat Bachofen, M., and E. R. Weibel. 1982. Structural alterations of lung parenchyma in the adult respiratory syndrome. Clin. Chest Med. 3:35–56.PubMed Bachofen, M., and E. R. Weibel. 1982. Structural alterations of lung parenchyma in the adult respiratory syndrome. Clin. Chest Med. 3:35–56.PubMed
11.
Zurück zum Zitat Dudek, S. M., and J. G. N. Garcia. 2001. Cytoskeleton regulation of pulmonary vascular permeability. J. Appl. Physiol. 91:1487–1500.PubMed Dudek, S. M., and J. G. N. Garcia. 2001. Cytoskeleton regulation of pulmonary vascular permeability. J. Appl. Physiol. 91:1487–1500.PubMed
12.
Zurück zum Zitat Kao, S. J., D. D. Liu, C. F. Su, and H. I. Chen. 2007. Niacinamide abrogates the organ dysfunction and acute lung injury caused by endotoxin. J. Cardiovasc. Pharmacol. 50(3):333–342.PubMedCrossRef Kao, S. J., D. D. Liu, C. F. Su, and H. I. Chen. 2007. Niacinamide abrogates the organ dysfunction and acute lung injury caused by endotoxin. J. Cardiovasc. Pharmacol. 50(3):333–342.PubMedCrossRef
13.
Zurück zum Zitat Frank, J. A., J. F. Pittet, C. Wray, and M. A. Matthay. 2008. Protection from experimental ventilator-induced acute lung injury by IL-1 receptor blockade. Thorax. 63:147–153.PubMedCrossRef Frank, J. A., J. F. Pittet, C. Wray, and M. A. Matthay. 2008. Protection from experimental ventilator-induced acute lung injury by IL-1 receptor blockade. Thorax. 63:147–153.PubMedCrossRef
14.
Zurück zum Zitat Cazzola, M., and R. Polosa. 2006. Anti-TNF-alpha and Th1 cytokine-directed therapies for the treatment of asthma. Curr. Opin. Allergy Clin. Immunol. 6(1):43–50.PubMedCrossRef Cazzola, M., and R. Polosa. 2006. Anti-TNF-alpha and Th1 cytokine-directed therapies for the treatment of asthma. Curr. Opin. Allergy Clin. Immunol. 6(1):43–50.PubMedCrossRef
15.
Zurück zum Zitat Stirling, R. J., and K. F. Chung. 2000. Future treatments of allergic diseases and asthma. Br. Med. Bull. 56(4):1037–1053.PubMedCrossRef Stirling, R. J., and K. F. Chung. 2000. Future treatments of allergic diseases and asthma. Br. Med. Bull. 56(4):1037–1053.PubMedCrossRef
16.
Zurück zum Zitat Bjordal, J. M., M. I. Johnson, V. Iversen, F. Aimbire, and R. A. B. Lopes-Martins. 2006. Low Level Laser Therapy (LLLT) and acute pain: A systematic review of possible mechanisms of action and clinical effects in randomized placebo-controlled trials. Photomed. Laser Surg. 24(2):160–170.CrossRef Bjordal, J. M., M. I. Johnson, V. Iversen, F. Aimbire, and R. A. B. Lopes-Martins. 2006. Low Level Laser Therapy (LLLT) and acute pain: A systematic review of possible mechanisms of action and clinical effects in randomized placebo-controlled trials. Photomed. Laser Surg. 24(2):160–170.CrossRef
17.
Zurück zum Zitat Milojevic, M., and V. Kuruc. 2004. The role of physical rehabilitation in the treatment of exudative pleurisy. Med. Pregl. 57(1–2):13–17.PubMedCrossRef Milojevic, M., and V. Kuruc. 2004. The role of physical rehabilitation in the treatment of exudative pleurisy. Med. Pregl. 57(1–2):13–17.PubMedCrossRef
18.
Zurück zum Zitat Landyshev, I. U. S., N. V. Avdeeva, N. D. Goborov, N. P. Krasavina, G. A. Tikhonova, and S. I. Tkacheva. 2002. Efficacy of low intensity laser irradiation and sodium nedocromil in the complex treatment of patients with bronchial asthma. Ter. Arkh. 74(3):25–28.PubMed Landyshev, I. U. S., N. V. Avdeeva, N. D. Goborov, N. P. Krasavina, G. A. Tikhonova, and S. I. Tkacheva. 2002. Efficacy of low intensity laser irradiation and sodium nedocromil in the complex treatment of patients with bronchial asthma. Ter. Arkh. 74(3):25–28.PubMed
19.
Zurück zum Zitat Aimbire, F., R. A. B. Lopes-Martins, R. Albertini, M. T. T. Pacheco, H. C. Castro-Faria-Neto, P. S. L. M. Leonardo, and J. M. Bjordal. 2007. Effect of Low-Level Laser therapy on hemorrhagic lesions by immune complex in rat lungs. Photomed. and Laser Surg. 25(2):112–117.CrossRef Aimbire, F., R. A. B. Lopes-Martins, R. Albertini, M. T. T. Pacheco, H. C. Castro-Faria-Neto, P. S. L. M. Leonardo, and J. M. Bjordal. 2007. Effect of Low-Level Laser therapy on hemorrhagic lesions by immune complex in rat lungs. Photomed. and Laser Surg. 25(2):112–117.CrossRef
20.
Zurück zum Zitat Aimbire, F., J. M. Bjordal, V. V. Iversen, R. Albertini, L. Frigo, M. T. Pacheco, H. C. Castro-Faria-Neto, M. C. Chavantes, R. M. Labat, and R. A. Lopes-Martins. 2006. Low level laser therapy partially restores trachea muscle relaxation response in rats with tumor necrosis factor alpha-mediated smooth airway muscle dysfunction. Lasers Surg. Med. 38(8):773–778.PubMedCrossRef Aimbire, F., J. M. Bjordal, V. V. Iversen, R. Albertini, L. Frigo, M. T. Pacheco, H. C. Castro-Faria-Neto, M. C. Chavantes, R. M. Labat, and R. A. Lopes-Martins. 2006. Low level laser therapy partially restores trachea muscle relaxation response in rats with tumor necrosis factor alpha-mediated smooth airway muscle dysfunction. Lasers Surg. Med. 38(8):773–778.PubMedCrossRef
21.
Zurück zum Zitat Akeson, A. L., C. W. Woods, L. C. Hsieh, R. A. Bohnke, B. L. Ackermann, K. Y. Chan, J. L. Robinson, S. D. Yanofsky, J. W. Jacobs, R. W. Barrett, and T. L. Bowlin. 1996. AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1. J. Biol. Chem. 271(48):30517–30523.PubMedCrossRef Akeson, A. L., C. W. Woods, L. C. Hsieh, R. A. Bohnke, B. L. Ackermann, K. Y. Chan, J. L. Robinson, S. D. Yanofsky, J. W. Jacobs, R. W. Barrett, and T. L. Bowlin. 1996. AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1. J. Biol. Chem. 271(48):30517–30523.PubMedCrossRef
22.
Zurück zum Zitat Shimada, H., N. Hasegawa, H. Koh, S. Tasaka, M. Shimizu, W. Yamada, T. Nishimura, K. Amakawa, M. Kohno, M. Sawafuji, K. Nakamura, S. Fujishima, K. Yamaguchi, and A. Ishizaka. 2006. Effects of initial passage of endotoxin through the liver on the extent of acute lung injury in a rat model. Shock 26(3):311–315.PubMedCrossRef Shimada, H., N. Hasegawa, H. Koh, S. Tasaka, M. Shimizu, W. Yamada, T. Nishimura, K. Amakawa, M. Kohno, M. Sawafuji, K. Nakamura, S. Fujishima, K. Yamaguchi, and A. Ishizaka. 2006. Effects of initial passage of endotoxin through the liver on the extent of acute lung injury in a rat model. Shock 26(3):311–315.PubMedCrossRef
23.
Zurück zum Zitat Wang, L. F., M. Patel, H. Razavi, S. Weicker, M. Joseph, D. McCormack, and S. Mehta. 2002. Role of inducible nitric oxide synthase in pulmonary microvascular protein leak in murine sepsis. Am. J. Respir. Crit. Care Med. 165:1634–1639.CrossRef Wang, L. F., M. Patel, H. Razavi, S. Weicker, M. Joseph, D. McCormack, and S. Mehta. 2002. Role of inducible nitric oxide synthase in pulmonary microvascular protein leak in murine sepsis. Am. J. Respir. Crit. Care Med. 165:1634–1639.CrossRef
24.
Zurück zum Zitat Tavares de Lima, W., A. A. Steil, M. Russo, N. Starobinas, C. F. Teixeira, and S. Jancar. 1998. Lipid mediators, tumor necrosis factor and nitric oxide and their interactions in immune-complex-induced lung injury. Eur. J. Pharmacol. 358(1):69–75.PubMedCrossRef Tavares de Lima, W., A. A. Steil, M. Russo, N. Starobinas, C. F. Teixeira, and S. Jancar. 1998. Lipid mediators, tumor necrosis factor and nitric oxide and their interactions in immune-complex-induced lung injury. Eur. J. Pharmacol. 358(1):69–75.PubMedCrossRef
25.
Zurück zum Zitat Goldblum, S. E., K. M. Wu, and M. Jay. 1985. Lung myeloperoxidase as a measure pf pulmonary leukostasis in rabbits. J. Appl. Physiol. 59:1978–1985.PubMed Goldblum, S. E., K. M. Wu, and M. Jay. 1985. Lung myeloperoxidase as a measure pf pulmonary leukostasis in rabbits. J. Appl. Physiol. 59:1978–1985.PubMed
26.
Zurück zum Zitat Dinarello, C. A. 1996. Biologic basis of interleukin-1 in disease. Blood 87(6):2095–2147.PubMed Dinarello, C. A. 1996. Biologic basis of interleukin-1 in disease. Blood 87(6):2095–2147.PubMed
27.
Zurück zum Zitat Borish, L., J. J. Mascali, J. Dishuck, W. R. Beam, R. J. Martin, and L. J. Rosenwasser. 1992. Detection of alveolar macrophage-derived IL-1b in asthma. Inhibition with corticosteroids. J. Immunol. 149:3340–3346. Borish, L., J. J. Mascali, J. Dishuck, W. R. Beam, R. J. Martin, and L. J. Rosenwasser. 1992. Detection of alveolar macrophage-derived IL-1b in asthma. Inhibition with corticosteroids. J. Immunol. 149:3340–3346.
28.
Zurück zum Zitat Peng, X., P. M. Hassoun, S. Sammani, B. J. McVerry, M. J. Burne, H. Rabb, D. Pearse, R. M. Tuder, and J. G. N. Garcia. 2004. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am. J. Respir. Crit. Care Med. 169:1245–1251.PubMedCrossRef Peng, X., P. M. Hassoun, S. Sammani, B. J. McVerry, M. J. Burne, H. Rabb, D. Pearse, R. M. Tuder, and J. G. N. Garcia. 2004. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am. J. Respir. Crit. Care Med. 169:1245–1251.PubMedCrossRef
29.
Zurück zum Zitat Gerlach, H., D. Keh, A. Semmerow, T. Busch, K. Lewandowski, D. M. Pappert, R. Rossaint, and K. J. Falke. 2003. Dose–response characteristics during long-term inhalation of nitric oxide in patients with severe acute respiratory distress syndrome: a prospective, randomized, controlled study. Am. J. Respir. Crit. Care Med. 167(7):1008–1015.PubMedCrossRef Gerlach, H., D. Keh, A. Semmerow, T. Busch, K. Lewandowski, D. M. Pappert, R. Rossaint, and K. J. Falke. 2003. Dose–response characteristics during long-term inhalation of nitric oxide in patients with severe acute respiratory distress syndrome: a prospective, randomized, controlled study. Am. J. Respir. Crit. Care Med. 167(7):1008–1015.PubMedCrossRef
30.
Zurück zum Zitat Pilkington, C. A., and L. R. Weddenburg. 2005. Pediatric idiopathic inflammatory muscle disease: recognition and management. Drugs 65(10):1355–1365.PubMedCrossRef Pilkington, C. A., and L. R. Weddenburg. 2005. Pediatric idiopathic inflammatory muscle disease: recognition and management. Drugs 65(10):1355–1365.PubMedCrossRef
31.
Zurück zum Zitat Chung, F. 2001. Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferon-g. Mediat. Inflamm. 10:51–59.CrossRef Chung, F. 2001. Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferon-g. Mediat. Inflamm. 10:51–59.CrossRef
32.
Zurück zum Zitat Alagappan, V. K., S. McKay, A. Widyastuti, I. M. Garrelds, A. J. Bogers, H. C. Hoogsteden, S. J. Hirst, and H. S. Sharma. 2005. Pro-inflammatory cytokines upregulate mRNA expression and secretion of vascular endothelial growth factor in cultured human airway smooth muscle cells. Cell Biochem. Biophys. 43(1):119–129.PubMedCrossRef Alagappan, V. K., S. McKay, A. Widyastuti, I. M. Garrelds, A. J. Bogers, H. C. Hoogsteden, S. J. Hirst, and H. S. Sharma. 2005. Pro-inflammatory cytokines upregulate mRNA expression and secretion of vascular endothelial growth factor in cultured human airway smooth muscle cells. Cell Biochem. Biophys. 43(1):119–129.PubMedCrossRef
33.
Zurück zum Zitat Kupfner, J. G., J. J. Arcaroli, H. K. Yum, S. G. Nadler, K. Y. Yang, and E. Abraham. 2001. Role of NF-kappaB in endotoxemia-induced alterations of lung neutrophil apoptosis. J. Immunol. 167(12):7044–7051.PubMed Kupfner, J. G., J. J. Arcaroli, H. K. Yum, S. G. Nadler, K. Y. Yang, and E. Abraham. 2001. Role of NF-kappaB in endotoxemia-induced alterations of lung neutrophil apoptosis. J. Immunol. 167(12):7044–7051.PubMed
34.
Zurück zum Zitat Niwa, M., A. Hara, Y. Kanamori, D. Hatakeyama, M. Saio, T. Takami, H. Matsuno, O. Kozawa, and T. Uematsu. 2000. Nuclear factor-kappaB activates dual inhibition sites in the regulation of tumor necrosis factor-alpha-induced neutrophil apoptosis. Eur. J. Pharmacol. 407(3):211–219.PubMedCrossRef Niwa, M., A. Hara, Y. Kanamori, D. Hatakeyama, M. Saio, T. Takami, H. Matsuno, O. Kozawa, and T. Uematsu. 2000. Nuclear factor-kappaB activates dual inhibition sites in the regulation of tumor necrosis factor-alpha-induced neutrophil apoptosis. Eur. J. Pharmacol. 407(3):211–219.PubMedCrossRef
35.
Zurück zum Zitat Coras, B., U. Hohenleutner, M. Landthaler, and S. Hohenleutner. 2005. Early recurrence of eruptive vellus hair cysts after Er:YAG laser therapy: case report and review of the literature. Dermatol. Surg. 31(12):1741–1744.PubMed Coras, B., U. Hohenleutner, M. Landthaler, and S. Hohenleutner. 2005. Early recurrence of eruptive vellus hair cysts after Er:YAG laser therapy: case report and review of the literature. Dermatol. Surg. 31(12):1741–1744.PubMed
36.
Zurück zum Zitat Witman, P. M., A. M. Wagner, K. Scherer, M. Waner, and I. J. Frieden. 2006. Complications following pulsed dye laser treatment of superficial hemangiomas. Lasers Surg. Med. 38(2):116–123.PubMedCrossRef Witman, P. M., A. M. Wagner, K. Scherer, M. Waner, and I. J. Frieden. 2006. Complications following pulsed dye laser treatment of superficial hemangiomas. Lasers Surg. Med. 38(2):116–123.PubMedCrossRef
37.
Zurück zum Zitat Lee, H. W., S. J. Ahn, M. W. Lee, J. H. Choi, K. C. Moon, and J. K. J. Koh. 2006. Pseudomelanoma following laser therapy. Eur. Acad. Dermatol. Venereol. 20(3):342–344.CrossRef Lee, H. W., S. J. Ahn, M. W. Lee, J. H. Choi, K. C. Moon, and J. K. J. Koh. 2006. Pseudomelanoma following laser therapy. Eur. Acad. Dermatol. Venereol. 20(3):342–344.CrossRef
38.
Zurück zum Zitat Chan, H. H., C. H. Yang, J. C. Leung, W. I. Wei, and K. N. Lai. 2007. An animal study of the effects on p16 and PCNA expression of repeated treatment with high-energy laser and intense pulsed light exposure. Lasers Surg. Med. 39(1):8–13.PubMedCrossRef Chan, H. H., C. H. Yang, J. C. Leung, W. I. Wei, and K. N. Lai. 2007. An animal study of the effects on p16 and PCNA expression of repeated treatment with high-energy laser and intense pulsed light exposure. Lasers Surg. Med. 39(1):8–13.PubMedCrossRef
39.
Zurück zum Zitat Dinarello, C. A. 2005. Interkeukin-1b. Crit. Care Med. 33(12):460–462.CrossRef Dinarello, C. A. 2005. Interkeukin-1b. Crit. Care Med. 33(12):460–462.CrossRef
40.
Zurück zum Zitat Albertini, R., F. Aimbire, A. B. Villaverde, J. A. Silva Jr, and M. S. Costa. 2007. COX-2 mRNA expression decreases in the subplantar muscle of rat paw subjected to carrageenan-induced inflammation after low level laser therapy. Inflamm. Res. 56:1–2.CrossRef Albertini, R., F. Aimbire, A. B. Villaverde, J. A. Silva Jr, and M. S. Costa. 2007. COX-2 mRNA expression decreases in the subplantar muscle of rat paw subjected to carrageenan-induced inflammation after low level laser therapy. Inflamm. Res. 56:1–2.CrossRef
Metadaten
Titel
Low Level Laser Therapy (LLLT) Decreases Pulmonary Microvascular Leakage, Neutrophil Influx and IL-1β Levels in Airway and Lung from Rat Subjected to LPS-Induced Inflammation
verfasst von
F. Aimbire
A. P. Ligeiro de Oliveira
R. Albertini
J. C. Corrêa
C. B. Ladeira de Campos
J. P. Lyon
J. A. Silva Jr.
M. S. Costa
Publikationsdatum
01.06.2008
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 3/2008
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-008-9064-4

Weitere Artikel der Ausgabe 3/2008

Inflammation 3/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.